Robert Holaj
Overview
Explore the profile of Robert Holaj including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
555
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Petrak O, Klimova J, Mraz M, Haluzikova D, Dolezalova R, Kratochvilova H, et al.
J Clin Endocrinol Metab
. 2020 Mar;
105(6).
PMID: 32222768
Context: Impaired glucose homeostasis is a common finding in pheochromocytoma (PHEO), especially with adrenergic phenotype. The possible contribution of incretin dysfunction to dysglycemia in PHEO patients has not been studied....
12.
Zelinka T, Petrak O, Rosa J, Holaj R, Strauch B, Widimsky Jr J
Kidney Blood Press Res
. 2020 Mar;
45(2):275-285.
PMID: 32114578
Objective: Primary aldosteronism (PA) may present at younger age and may thus complicate pregnancy. Our aim was to identify female patients in whom PA was diagnosed after pregnancy complicated with...
13.
Petrak O, Rosa J, Holaj R, Strauch B, Kratka Z, Kvasnicka J, et al.
J Clin Endocrinol Metab
. 2019 Apr;
104(11):5170-5180.
PMID: 31009053
Context: Impaired diurnal blood pressure (BP) variability is related to higher cardiovascular risk. Objective: To assess diurnal variability of BP and its relation to target organ damage (TOD) and catecholamine...
14.
Klimova J, Zelinka T, Rosa J, Strauch B, Haluzikova D, Haluzik M, et al.
Cancers (Basel)
. 2019 Apr;
11(4).
PMID: 30959789
Fibroblast growth factor 21 (FGF21) is a hepatokine with beneficial effects on metabolism. Our aim was to evaluate the relationship between the serum FGF21, and energy and glucose metabolism in...
15.
Kvasnicka J, Zelinka T, Petrak O, Rosa J, Strauch B, Kratka Z, et al.
Cancers (Basel)
. 2019 Mar;
11(3).
PMID: 30845735
: Pheochromocytomas (PHEO) are tumors arising from chromaffin cells from the adrenal medulla, having the ability to produce, metabolize and secrete catecholamines. The overproduction of catecholamines leads by many mechanisms...
16.
Gupta P, Patel P, Strauch B, Lai F, Akbarov A, Maresova V, et al.
Hypertension
. 2017 May;
69(6):1113-1120.
PMID: 28461599
Nonadherence to antihypertensive treatment is a critical contributor to suboptimal blood pressure control. There are limited and heterogeneous data on the risk factors for nonadherence because few studies used objective-direct...
17.
Rosa J, Widimsky P, Waldauf P, Zelinka T, Petrak O, Taborsky M, et al.
J Hypertens
. 2017 Jan;
35(5):1093-1099.
PMID: 28118281
Objectives: The randomized, multicentre study compared the efficacy of renal denervation (RDN) versus spironolactone addition in patients with true resistant hypertension. We present the 24-month data. Methods: A total of...
18.
Majtan B, Zelinka T, Rosa J, Petrak O, Kratka Z, Strauch B, et al.
J Clin Endocrinol Metab
. 2016 Dec;
102(4):1208-1217.
PMID: 28001459
Context: Catecholamines may contribute to the accumulation of collagen fibers and extracellular matrix in the arterial and myocardial wall due to various mechanisms. Reversibility of this process has not been...
19.
Rosa J, Zelinka T, Petrak O, Strauch B, Holaj R, Widimsky Jr J
Curr Hypertens Rep
. 2016 Oct;
18(11):81.
PMID: 27787836
Purpose Of Review: Resistant hypertension is a common clinical situation. Identification of true resistant hypertension (using 24-h ambulatory blood pressure monitoring to exclude white coat phenomenon, excluding secondary causes and...
20.
Rosa J, Widimsky P, Waldauf P, Lambert L, Zelinka T, Taborsky M, et al.
Hypertension
. 2015 Dec;
67(2):397-403.
PMID: 26693818
This randomized, multicenter study compared the relative efficacy of renal denervation (RDN) versus pharmacotherapy alone in patients with true resistant hypertension and assessed the effect of spironolactone addition. We present...